PRDX1, has been identified as a biomarker helpful in the diagnosis of several diseases, including ovarian cancer [55], abdominal aortic aneurysm [65], pancreatic cancer [66], and irritable bowel syndrome [67]. Here, PRDX1 is linked to familial pancreatic carcinoma.